Skip to main content
CDC Website

The NPIN Community Portal will shut down on Nov. 1. Click here to learn more.

Search Results

Results 61 - 70 of 17827

Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support research towards identifying and characterizing neuroimmune networks, communication pathways, and targets that reside within neuroimmune axes, in the context of HIV and substance use. This NOFO will also support research on the...

Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)

Application Due Date:
Funding Organization:
US Department of Health and Human Services
National Institutes of Health

Stimulant use has been increasing among opioid users since 2016, based on overdose data and this makes control of the opioid epidemic more difficult, as it occurs in addition to the continuing influx of fentanyl and related compounds. Stimulant/opioid users present unfamiliar clinical issues to...

Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The goals of this initiative are to examine mechanisms of reciprocal interactions between HIV-associated neuroinflammation and CNS persistence in the setting of excellent virologic control using novel CNS cell systems, organoid models and single cell technologies

Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The goals of this initiative are to examine mechanisms of reciprocal interactions between HIV-associated neuroinflammation and CNS persistence in the setting of excellent virologic control using novel CNS cell systems, organoid models and single cell technologies

The Harm Reduction Futures Fund

Application Due Date:
Funding Organization:
AIDS United

In Round 15, the Harm Reduction Futures Fund will prioritize support for programs that are led by and serve Black, Indigenous, and other People of Color (BIPOC) and those in jurisdictions of high need and low resources. Other compelling factors may include the leadership of current or former sex...

Ending the HIV Epidemic in the U.S. Systems Coordination Provider

Application Due Date:
Funding Organization:
The US Department of Health and Human Services Health Resources and Services Administration

The purpose of this program is to fund TA and systems coordination for the 48 counties, Washington, D.C., San Juan, Puerto Rico (PR), and seven states (hereafter referred to as “jurisdictions”) identified in and funded through HRSA-20-078 (the funded entities hereafter referred to as “recipients”)...

Ending the HIV Epidemic in the U.S. Technical Assistance Provider

Application Due Date:
Funding Organization:
The US Department of Health and Human Services Health Resources and Services Administration

The purpose of this program is to fund TA and systems coordination for the 48 counties, Washington, D.C., San Juan, Puerto Rico (PR), and seven states (hereafter referred to as “jurisdictions”) identified in and funded through HRSA-20-078 (the funded entities hereafter referred to as “recipients”)...

Ending the HIV Epidemic in the U.S. Ryan White HIV/AIDS Program Parts A and B

Application Due Date:
Funding Organization:
The US Department of Health and Human Services Health Resources and Services Administration

The purpose of this initiative is to focus resources in 48 counties, Washington, D.C., San Juan, Puerto Rico (PR), and seven states with the highest incidence or burden of HIV to implement effective and innovative strategies, interventions, approaches, and services to reduce new HIV infections in...

Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support basic and applied research to define the mechanisms for establishing, developing and maintaining immunity to HIV in early life (from birth to less than 12 years of age), including the impact of prophylactic vaccination and...

Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program

Application Due Date:
Funding Organization:
The US Department of Health and Human Services Health Resources and Services Administration

This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part A HIV Emergency Relief Grant Program. The purpose of this program is to provide direct financial assistance to an eligible metropolitan area (EMA) or transitional grant area (TGA) that has...